Inhibitory effects of alendronate on cholinergic responses in rat lower esophageal sphincter

Eur J Pharmacol. 2006 May 10;537(1-3):155-9. doi: 10.1016/j.ejphar.2006.03.027. Epub 2006 Mar 18.

Abstract

Alendronate is a potent inhibitor of osteoclast-mediated bone resorption, but its use results in serious esophageal damage. In order to clarify the latter, we examined the effects of alendronate on electrical field stimulation-induced responses in the rat lower esophageal sphincter. Electrical field stimulation induced atropine-sensitive contraction. Alendronate inhibited electrical field stimulation-induced contraction in a concentration-dependent manner. In the presence of N(G)-nitro-L-arginine (L-nitroarginine), electrical field stimulation elicited a strong cholinergic contraction. This contraction was also inhibited by alendronate, to a similar extent as that seen in the absence of L-nitroarginine. In lower esophageal sphincter contracted by prostaglandin F(2alpha) and treated with atropine, electrical field stimulation induced L-nitroarginine-sensitive relaxation. Alendronate did not affect relaxation. These results suggest that alendronate decreases the tone of lower esophageal sphincter by inhibiting cholinergic nervous activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Alendronate / pharmacology*
  • Animals
  • Bone Density Conservation Agents / pharmacology*
  • Cholinergic Antagonists / pharmacology*
  • Electric Stimulation
  • Esophageal Sphincter, Lower / drug effects*
  • Esophageal Sphincter, Lower / physiology
  • Gastric Fundus / drug effects
  • Gastric Fundus / physiology
  • Ileum / drug effects
  • Ileum / physiology
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Rats
  • Rats, Wistar

Substances

  • Bone Density Conservation Agents
  • Cholinergic Antagonists
  • Acetylcholine
  • Alendronate